These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19893765)

  • 21. Controlling signaling with a specifically designed Gi-coupled receptor.
    Coward P; Wada HG; Falk MS; Chan SD; Meng F; Akil H; Conklin BR
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):352-7. PubMed ID: 9419379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
    Abdul-Ridha A; Lane JR; Sexton PM; Canals M; Christopoulos A
    Mol Pharmacol; 2013 Feb; 83(2):521-30. PubMed ID: 23197649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemogenetic Signaling in Space and Time: Considerations for Designing Neuroscience Experiments Using DREADDs.
    Clark PJ; Brodnik ZD; España RA
    Neuroscientist; 2024 Jun; 30(3):328-346. PubMed ID: 36408535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs.
    Burnett CJ; Krashes MJ
    J Neurosci; 2016 Sep; 36(36):9268-82. PubMed ID: 27605603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemogenetic Tools and their Use in Studies of Neuropsychiatric Disorders.
    Neřoldová M; Stuchlík A
    Physiol Res; 2024 Aug; 73(S1):S449-S470. PubMed ID: 38957949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs.
    Wang L; Zhu L; Meister J; Bone DBJ; Pydi SP; Rossi M; Wess J
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():421-440. PubMed ID: 32746768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
    Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
    Elife; 2020 Feb; 9():. PubMed ID: 32096468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts.
    Liebmann C
    Curr Pharm Des; 2004; 10(16):1937-58. PubMed ID: 15180530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cre-dependent DREADD (Designer Receptors Exclusively Activated by Designer Drugs) mice.
    Zhu H; Aryal DK; Olsen RH; Urban DJ; Swearingen A; Forbes S; Roth BL; Hochgeschwender U
    Genesis; 2016 Aug; 54(8):439-46. PubMed ID: 27194399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative assessment of the effects of DREADDs and endogenously expressed GPCRs in hippocampal astrocytes on synaptic activity and memory.
    Lee SH; Mak A; Verheijen MHG
    Front Cell Neurosci; 2023; 17():1159756. PubMed ID: 37051110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A synthetic method to assay adhesion-family G-protein coupled receptors. Determination of the G-protein coupling profile of ADGRG6(GPR126).
    Lizano E; Hayes JL; Willard FS
    Biochem Biophys Res Commun; 2021 Jan; 534():317-322. PubMed ID: 33248691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deciphering and modulating G protein signalling in C. elegans using the DREADD technology.
    Prömel S; Fiedler F; Binder C; Winkler J; Schöneberg T; Thor D
    Sci Rep; 2016 Jul; 6():28901. PubMed ID: 27461895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remote control of neuronal signaling.
    Rogan SC; Roth BL
    Pharmacol Rev; 2011 Jun; 63(2):291-315. PubMed ID: 21415127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.
    Kapolka NJ; Taghon GJ; Rowe JB; Morgan WM; Enten JF; Lambert NA; Isom DG
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13117-13126. PubMed ID: 32434907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How structure informs and transforms chemogenetics.
    Roth BL
    Curr Opin Struct Biol; 2019 Aug; 57():9-16. PubMed ID: 30818201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL).
    Claeysen S; Joubert L; Sebben M; Bockaert J; Dumuis A
    J Biol Chem; 2003 Jan; 278(2):699-702. PubMed ID: 12441358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified yeast cells to investigate the coupling of G protein-coupled receptors to specific G proteins.
    Ladds G; Davis K; Hillhouse EW; Davey J
    Mol Microbiol; 2003 Feb; 47(3):781-92. PubMed ID: 12535076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research progress in signal bias of G protein-coupled receptor and its mechanism].
    Zhai PB; Ma L; Liu X
    Sheng Li Xue Bao; 2016 Dec; 68(6):790-798. PubMed ID: 28004074
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.